Page last updated: 2024-08-23

azides and Lymphoma, T-Cell

azides has been researched along with Lymphoma, T-Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benacerraf, B; Clark, K; Kovacsovics-Bankowski, M; Rock, KL1
Ling, V; Rischin, D1

Other Studies

2 other study(ies) available for azides and Lymphoma, T-Cell

ArticleYear
Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.
    Proceedings of the National Academy of Sciences of the United States of America, 1993, Jun-01, Volume: 90, Issue:11

    Topics: Animals; Antigen-Presenting Cells; Azides; Cell Line; Cytochalasin B; Deoxyglucose; Female; Histocompatibility Antigens Class I; Kinetics; Lymphoma, T-Cell; Macrophages; Mast-Cell Sarcoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Ovalbumin; Phagocytosis; Spleen; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured

1993
Ormaplatin resistance is associated with decreased accumulation of its platinum (II) analogue, dichloro(D,L-trans)1,2-diaminocyclohexaneplatinum (II).
    British journal of cancer, 1996, Volume: 74, Issue:4

    Topics: Animals; Antineoplastic Agents; Azides; Biological Transport; Carboplatin; Cell Line; Chromatography, High Pressure Liquid; Cisplatin; Drug Resistance, Neoplasm; Kinetics; Lymphoma, T-Cell; Mice; Organoplatinum Compounds; Sodium Azide; Sulfhydryl Compounds; Tumor Cells, Cultured

1996